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Abstract  
A model that predicts levels of coronavirus (CoV) respiratory/fecal-oral transmission potentials 
based on the outer shell hardness has been built using neural network (artificial intelligence, AI) 
analysis of the percentage of disorder (PID) in the nucleocapsid, N, and membrane, M, proteins of 
the inner and outer viral shells, respectively. Based mainly on the PID of N, SARS-CoV-2 is 
categorized as having intermediate levels of both respiratory and fecal oral transmission potential. 
Related to this, other studies have found strong positive correlations between virulence and inner 
shell disorder among numerous viruses, including Nipah, Ebola, and Dengue viruses. There is some 
evidence that this is also true for SARS-CoV-2 and SARS-CoV, which have N PIDs of 48% and 
50%, and are characterized by case-fatality rates of 7.1% and 10.9%, respectively. The link between 
levels of respiratory transmission and virulence lies in viral load of body fluids and organ 
respectively. A virus can be infectious via respiratory modes only if the viral loads in saliva and 
mucus exceed certain minima. Likewise, a person may die, if the viral load is too high especially in 
viral organs. Inner shell proteins of viruses play important roles in the replication of viruses, and 
structural disorder enhances these roles by providing greater efficiency in protein-
protein/DNA/RNA/lipid binding. This paper outlines a novel strategy in attenuating viruses 
involving comparison of disorder patterns of inner shells of related viruses to identify residues and 
regions that could be ideal for mutation. The M protein of SARS-CoV-2 has one of the lowest M 
PID values (6%) in its family, and therefore this virus has one of the hardest outer shells, which 
makes it resistant to antimicrobial enzymes in body fluid. While this is likely responsible for its 
contagiousness, the risks of creating an attenuated virus with a more disordered M are discussed.  
 
Key words: intrinsic; disorder; protein; nucleocapsid; Nipah; virulence; viral protein; protein 
structure; protein function, shell; covid;coronavirus; ebola;vaccine; immune; antibody;shell; 
nucleocapsid; nucleoprotein; matrix;attenuate; 
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Introduction 
SARS-CoV-2 (COVID-19) 
The coronavirus infectious disease 2019 (COVID-19) is caused by the severe acute respiratory 
syndrome coronavirus-2 (SARS-CoV-2) [1]. The first sign of the SARS-CoV-2 spread was reported 
in December 2019 at a Wuhan seafood market in China that also sold live animals [2-5]. Since then, 
COVID-19 has become an extremely serious pandemic with confirmed global infections and deaths 
moving quickly towards 3.5 million and 250,000 respectively. The current case-fatality rate of 
COVID-19 is 7.1%. SARS-CoV-2 is closely related to SARS-CoV that caused an outbreak in 2002-
2003 but was more contagious (it showed the case-fatality rate of 10.9%). 
 
Intermediate levels of both fecal-oral and respiratory transmission potentials 
predicted for SARS-CoV-2 and SARS-CoV 
A model was built before the MERS-CoV outbreak in 2012. This model measured the percentage of 
intrinsic disorder (PID) of proteins from the viral inner and outer shells, the nucleocapsid, N, 
membrane protein, M, respectively [6,7]. Upon the tabulation of the PIDs, the CoVs were clustered 
into three groups (Table 1). The first group, group A, consists of coronaviruses that have lower 
fecal-oral but higher respiratory transmission potentials. Group B are CoVs that have intermediate 
levels of fecal-oral and respiratory potentials. Lastly, group C includes viruses that have higher 
fecal-oral, but lower respiratory transmission potentials. The clustering is based mainly on PID 
values of corresponding N proteins, even though later statistical analysis detected that PID values of 
M proteins also slightly contribute to the categorization. The model indicated that SARS-CoV 
(PIDM = 8%, PIDN = 50%) falls into category B, which is indicative of intermediate levels of both 
fecal-oral and respiratory transmission levels.  
Chances for further validation of the model came with the 2012 MERS-CoV and the 2019 COVID 
(SARS-CoV-2) outbreaks. Proteomic and genetic analyses of the viruses indicates that MERS-CoV 
Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 7 May 2020                   
(PIDM = 9%, PIDN = 44%) and SARS-CoV-2 (PIDM =6%, PIDN = 48%) belong to the categories C 
and B respectively, according to the model already established [2-3,7,8]. These results are consistent 
with clinical and other observations. MERS-CoV originated from a zoonotic transmission event of a 
camel coronavirus. Since fecal-oral transmission is generally the most efficient mode of 
transmissions among farm animals, including camels, this could evolutionary account for the high 
fecal-oral transmission potential of MERS-CoV as predicted by the model [9,10]. SARS-CoV-2, on 
the other hand, falls into the same category B as its closely related cousin, SARS-CoV, with the 
intermediate levels of both respiratory and fecal-oral transmission potentials.  
 
Reason for higher SARS-CoV-2 infectivity: Harder outer shell, greater resilience and, 
thus, greater contagiousness 
The model detects, however, something else odd about SARS-CoV-2 and shows that its outer shell 
is among the hardest outer shells (i.e., low PIDM = 6%) within the CoV family. As the outer shell 
plays the greatest role in protecting the virion, it is therefore likely that SARS-CoV-2 should be 
more resistant to the antimicrobial enzymes found on the tongue and skin or in saliva, mucus, and 
other body fluids. As a result, the body is capable of shedding more viral particles. This might 
account for the fact that SARS-CoV-2 is more contagious than SARS-CoV. 
  
Inner shell disorder (N protein): A novel vaccine target 
Enigmatically, in other viruses analyzed by the model, such as Ebolavirus (EBOV), Nipah virus 
(NiV), Dengue (DENV) and flaviviruses, the inner shell disorder was also found to be correlated 
with the level of virulence [7,10-13]. It is for this reason, the inner shells have been seen as 
potential vaccine targets. Our previous paper has briefly examined the relationship between the 
virulence and respiratory transmission potentials via analysis of the inner shell disorder and protein 
binding promiscuity [3]. This paper will examine in greater details the strategy of using 
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nucleocapsid (N) as a vaccine target not just for SARS-CoV-2, but also for a variety of related and 
unrelated viruses. 
 
Disorder prediction tools and reproducibility of the model 
Predictors of protein intrinsic disorder and other sequence analysis tools 
A major concept used in the study is the phenomenon of protein intrinsic disorder, which refers to 
proteins or protein regions that have no unique 3D structure. While protein structures are linked to 
protein functions via classic protein structure-function paradigm (where unique protein sequence 
encodes unique 3D structure that is responsible for unique biological function), protein disorder, 
likewise, has been linked to myriads of protein functions [14-16]. Tools have been developed to 
predict disorder, since disordered and ordered proteins are characterized by specific and therefore 
predictable features of their amino acid sequences. The first of these disorder predictors is the 
PONDR® VLXT (www.pondr.com), which is a neural network (artificial intelligence: AI) trained to 
recognize disordered and ordered sequences [17-19]. 
PONDR® VLXT has been highly successful when used to study viral proteins, especially viral shell 
proteins, since many of these proteins are structural proteins held together by protein-protein or 
protein-RNA/DNA interactions, and PONNDR® VLXT is known to be one of the best predictors 
that can take into account these factors [20,21]. It is for these reasons PONDR® VLXT has been 
successfully used in the study of a large variety of viruses including human immunodeficiency virus 
(HIV), herpes simplex virus (HSV), hepatitis C virus (HCV), NiV, EBOV, 1918 HIN1 influenza A 
virus, CoVs, and flaviviruses including yellow fever (YFV), Zika (ZIKV), DENV [2-3,6-8,10-
13,23-31]. 
An important number that is used as a yardstick to measure the level of disorder in a protein is the 
percentage of intrinsic disorder (PID), which is defined as the number of residues predicted to be 
disordered divided by the total number of residues in a protein. The sequences are available at UniProt 
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(http:www.uniprot.org) and NCBI (https://www.ncbi.nlm.nih.gov/nuccore/MN908947). Relational 
database is used to store disorder and sequence information [22]. Statistical calculations using 
multivariate analysis were done using R statistical package [28]. Basic Alignment Search Tools for 
Proteins (BLASTP) is available at NCBI (https://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE=Proteins).  
 
 
Revisiting the CoV shell disorder model 
As aforementioned, the CoV shell disorder model is based on the disorder levels of two major shell 
proteins: M (membrane, outer shell) and N (nucleocapsid, inner shell) [7,29]. Table 1 shows the 
grouping of the three category of coronaviruses. Figure 1 tells us that the SARS-CoV-2 is odd as its 
outer shell (M) is among the hardest in the family given its low PIDM value, which is likely 
indicative of greater resistance of this virus to antimicrobial enzymes found in the saliva, mucus, 
tongue, and skin [2,3]. This characteristic is believed to cause greater shedding of viral particles that 
is responsible for its greater contagiousness. There is, however, at least one other “competing” 
theory that could also accounts for the greater contagiousness of SARS-CoV-2. This involves the 
discovery that the spike (S) glycoprotein binds 20-30 times more tightly to the angiotensin 
converting enzyme-2 (ACE2) receptor than in the case of SARS-CoV [30]. While this finding does 
not discount, in any way, the results found in Table1 and Figure 1, it raises questions pertaining to 
the true cause of its contagiousness. With a high probability, both of these factors contribute to the 
higher transmission potential of SARS-CoV-2. 
 
Incoming COVID-19 data supporting the CoV shell model  
Incoming clinical data are increasingly providing compelling evidence that the SARS-CoV-2 sheds 
large quantities of infectious particles. Heavy viral shedding has been detected on the first day when 
the patients showed the slightest symptom [31] or even no symptom [32]. The heavy shedding 
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lasted until the days of recovery. This shedding was observed to be much greater among COVID-19 
patients than those infected with SARS-CoV [31]. Large amounts of virions are not confined to the 
respiratory tract and spread in a form of respiratory droplets, but can also be found in fecal matters. 
The infectious particles were observed to be active for a prolonged period of time [33]. Needless to 
say, these are consistent with all the predictions that our model has made, including the greater 
probability that the viral particles will remain active for a longer period of time, since SARS-COV-2 
has one of the hardest outer shells in its family, and that the SARS-COV-2 has intermediate levels 
of both respiratory and fecal-oral transmission potentials.  
 
Lineage, intermediary hosts, and PIDM and PIDN values  
A glance at the PIDN values of various CoVs in Figure 1 tells us that the neighboring viruses with 
similar PIDN values are bat coronaviruses. Not only this corroborates with phylogenetic studies 
showing that one of the bat CoVs (RATG13) has as much as 96% similarity to SARS-CoV-2 [4,5], 
it highlights the evolutionary connection between this virus and bat CoV. One interpretation would 
be that the PIDN in the range of 47-48% defines the optimal respiratory transmission potential to 
spread among the bats. If this is the case, then the N protein from SARS-CoV-2 did not evolve 
much, if any, and is ton too different from its ancestral counterpart in bat CoV, even if there is an 
intermediary host before the appearance of CoV capable of infecting humans. This is in sharp 
contrast to its close cousin, SARS-CoV, which has PIDN of 50%, which could imply that the N 
protein from SARS-CoV probably had time to evolve in an intermediary host, such as civet cat.     
A different story can be found while looking at the PIDM values in different viruses. This is not 
contradictory, as different proteins affect organisms differently. For instance, a virus may need more 
immediate protection by evolving a harder outer shell (more rigid M protein), if it moves to a new 
host species that has stronger antimicrobial enzymes in its saliva [2,3]. Figure 1 shows that very 
few other CoVs have such low PIDM values as SARS-CoV-2 and, unlike disorder levels in N 
proteins, none of the ARS-CoV-2 bat cousins are close to such low PIDM. The closest counterparts 
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found in this sample include canine-respiratory CoV and bovine CoV. This is likely a reflection of 
the possibility that SARS-CoV-2 M protein had evolved in an intermediary host. Indeed, there have 
been much debate with regard the possibility of a snake or pangolin could serve as intermediary 
host for SARS-CoV-2 [34,35]. Furthermore, SARS-CoV-2 is now know to infect domesticated 
animals, such as cats and dogs [36]. Our model seems to imply that there is probably a non-bat 
intermediary host that the virus had for just enough time for its M protein to evolve, but its N 
protein probably needed a longer time to evolve outside the original bat host, and our data show that 
the N protein did not have a chance to evolve in an animal host other than bats. 
 
Links between virulence and inner shell disorder  
Links among modes of transmission and virulence with inner shell (N) disorder 
 Correlations between inner shell disorder and virulence have been previously discovered among a 
large variety of viruses, such as NiV, EBOV and flaviviruses, such as Zika (ZIKV), Dengue 
(DENV), and yellow fever (YFV) viruses.  Figure 2 represents the links between case-fatality rates 
(CFR) and inner shell disorder levels among a variety of viruses. While Figure 2A show some 
evidence of a link between SARS-CoV/SARS-CoV-2 virulence and PIDN, Figures 2B [12], 2C 
[13], 2D [10] and 2E [11] show correlations between inner shell disorder and CFRs of NiV, 
filoviruses (including EBOV), DENV, and flaviviruses respectively. While noting that DENV 
(Figure 2D) is a flavivirus (Figure  2E), Figures 2A, 2B, 2C and 2D-E represents groups of RNA 
viruses that are not related between groups. For this reason, somewhat different nomenclatures and 
abbreviations are used for the major inner shell protein chosen from different family of viruses. The 
nucleocapsid, nucleoprotein, and capsid of NiV, EBOV, and DENV are denoted by N, NPm and C 
respectively [29].  As also seen in Figure 1, the coefficients of determination (r2) of greater than 
0.25 for the various viruses reveal strong correlations between virulence and inner shell disorder.  
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PIDN and CFR values of SARS-CoV and SARS-CoV-2 suggest a link between 
virulence and N disorder  
Figure 2A shows that there is a link between SARS CFR and PIDN. Reasonably and commonly 
measured CFR for SARS-CoV-2 is in the range of 3-7%. SARS-CoV-2 is generally believed to be 
less severe than SARS-CoV, which has a CFR of about 10% [37-39].  However, it should be noted 
that establishing a link between virulence and PIDN among CoV is an intricate matter, since CoVs 
are genetically diverse and have 4 genera. Furthermore, CoVs infects a large variety of animal hosts 
with different virulence and often use different host receptors.  For instance, both SARS-CoV and 
SARS-CoV-2 enter the host cell using ACE2 receptor, while MERS-CoV uses dipeptidyl peptidase-
4  DPP4 [7,30]. Even more confusingly, MERS-CoV has a 35% CFR for humans, but is generally 
harmless to its predominant camel host [9]. Incidentally, SARS-CoV and SARS-CoV-2 lies within 
the same lineage of β-CoVs and share close to 80% in genomic sequence identity, whereas MERS-
CoV has only 50% sequence similarity to SARS-CoV-2 [40]. For these reasons, MERS-CoV cannot 
be included in the correlation.  
HCOVs that are distantly related to SARS-CoV and SARS-CoV-2 should also not be included. For 
instance, HCOV-NL63 should not be included even though it also enters human host using the 
ACE2, but in a different manner from SARS-CoV/SARS-CoV-2 [41,42].  HCOV-NL3 and HCOV-
229E are α-CoVs [43], while SARS-CoV, SARS-CoV-2 and MERS-CoV are in the β-CoV genus 
[29,35]. Because of the distant relationship between SARS-CoV/SARS-CoV-2 and HCOV-
229e/NL63, their sequence similarity is much lower than 50%, similar to what we have seen in the 
case of MERS-CoV and SARS-CoV-2. In fact, a sequence similarity study of the S proteins of 
SARS-CoV-2 and HCOV-NL63 has shown the percentage of identity to be as low as 14% [40].  
Given these, it is only reasonable that HCOV-229e/NL63 should not be also included into this 
analysis. 
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Link between virulence and modes of transmission:  Promiscuous 
protein-protein binding via inner shell disorder  
Links between modes of transmission and N disorder: NiV and CoV 
Upon the examination of Table 1 and Figure 2E, one can see that there is also a link between the 
transmission modes and virulence and the inner shell disorder. This link has also been found in NiV. 
While Figure 2B shows correlation between NiV PIDN and virulence, the NiV 1998-9 strain did not 
involve human to human transmission, unlike the other strains. Transmission during the Malaysian 
1998-1999 outbreak involved mainly farmers, who were infected during handling of pigs and their 
fecal matters, whereas the human-to-human spread that involve respiratory transmission did 
commonly occur in other strains [12]. Because the 1998-1999 strain has the lowest CFR and PIDN 
with the lowest observed respiratory transmission, a positive correlation between PIDN and level of 
viral respiratory transmission potentials has been detected. Likewise, a positive correlation between 
N disorder and respiratory transmission potential has already been seen in Table 1.   
 
Links among virulence, respiratory transmission potential, and N disorder: Viral 
loads in the body and in body fluids  
The afirementioned link among virulence, modes of transmission, and disorder of N protein may 
seem like a perplexing enigma, but it is not. When we built the CoV shell model before 2012, the 
viruses were clustered into levels of respiratory potentials in line with the ordering of PIDN. The 
reason has to do with the fact that the viral loads found in saliva and mucus of the infected person 
have to be above certain minimal levels before the virus can becomes infectious via the respiratory 
modes of transmission [2,3]. Similarly, in the case of virulence, death often occurs when the viral 
load in the human body crosses a certain threshold [7,11-13,18,24-27] . Inner shell disorder holds 
the connection for these two phenomena, as the inner shell is intimately involved in the viral 
replication process.  
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The “Trojan horse” immune evasion: Replicating quickly via N disorder before the 
immune system detects its presence  
Similar proteins often share similar functions even in unrelated viruses [29]. This is especially the 
case for the nucleocapsid proteins, which are known to play important and similar roles in the 
replication of viral particles in the host cell [7,25,44-46]. During these processes, they are known to 
bind to proteins that are part of the host replicating machinery, and by being more disordered, they 
show greater binding efficiency, as the disorder is known to be associated with more promiscuous 
protein-protein interactions [14-16,47]. The ability to replicate quickly before the onset of immune 
response is part of a “Trojan horse” immune evasion strategy [7].  Often, though, this strategy 
backfires on the virus, as the high viral load overwhelms the host organs and thus leads to death of 
the host. This is the reason that correlations of virulence and inner shell disorder are easily found in 
a large variety of related and unrelated viruses. The ability to rapidly replicate utilizing the 
advantages of the inner shell disorder is also manifested as greater respiratory potentials, as this will 
also allow for greater viral load in body fluids, such as saliva and mucus, not just in the blood and 
internal organs. 
 
Functional similarity of inner shells across viruses and the advantages of more 
promiscuous binding arising from greater levels of disorder 
It has long been known that greater disorder levels in the proteins are associated with the greater 
ability of proteins to be promiscuous binders; i.e., to interact with a greater variety of partners, 
including lipids, RNA/DNA, and proteins with higher efficiency [14-16,47]. This trait is likely to be 
of advantage, when a viral protein needs to bind to host proteins with greater effectiveness, as a part 
of the process of the hijacking of the host cell machinery. The inner shell proteins play crucial roles 
in the replication of infectious viral particles and their disorder helps with the rapid replication.   
There are plenty of opportunities for protein intrinsic disorder to play vital roles, when binding 
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between the viral and host proteins are considered. For instance, CoVs N protein transport viral 
proteins and RNA to areas near the endoplasmic reticulum (ER) and Golgi apparatus, where it helps 
in the packaging of viral particles [3,25,46]. Likewise, the C protein precursor from a flavivirus 
would egress and then bind to the membrane of the ER, where it interacts with other viral proteins 
and RNA for assembly and budding [7,10,11,29]. As for EBOV, its NP is responsible for the 
building of tube-like structures that facilitates the transportation and budding of viral particles [13, 
44]. Lastly, the greater disorder in the NiV N protein provides important means for the more 
efficient binding of this protein to P and L proteins to form a complex, which becomes an RNA 
polymerase responsible for the viral RNA replication [12,45]. We can now see that the inner shell 
proteins of the various viruses often play similar roles that provide for ample opportunities for 
protein intrinsic disorder to contribute to more efficient interactions with the host and viral proteins, 
DNA/RNA and lipids. Needless say, the greater efficiency of these interactions leads to quicker 
replication of viral particles. 
 
Strategies for attenuated vaccine development via analysis of inner 
shell disorder  
Attenuating the virus such that it does not replicate rapidly by increasing order in N  
We have seen that inner shell disorder is likely to be responsible for fast replication of many 
viruses. Since this virulence arises form the increased viral load caused by greater disorder in the 
inner shell protein, a strategy for developing an attenuated vaccine would be to find ways of 
reducing disorder of N protein in the case of SARS-CoV-2. It would be most ideal if an attenuated 
virus could still replicate but only very slowly, such that it will maintain the lowest possible viral 
load.  
Figure 3 shows the RNA binding domain of the N proteins of SARS-CoV-2 and murine hepatitis 
virus (MHV) with the disordered regions represented in red. It can be observed that the N protein 
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from SARS-CoV-2 (Figure 3A) contains noticeably more disordered regions than the N protein 
from MHV (Figure 3B), even though the MHV PIDN (46%) is just moderately lower than the 
SARS-CoV-2 PIDN (48%).  Since Figure 3 represents the structures of the RNA binding domain, it 
is likely that the greater disorder differences lie in this region. The reason that MHV is chosen in 
Figure 3B is that its data is easily accessible in PDB. There are, of course, CoVs with lower PIDN 
values as seen in Table 1.  One illustrative example is shown in Figure 4 representing data for the 
close cousin of MHV, HCOV-HKU1, which has the lowest PIDN among the CoV samples shown in 
Table 1. 
 
Choosing regions and residues to mutate using comparative disorder pattern 
We have seen that N disorder is likely a large factor in virulence, as it might contributes to greater 
viral load in the body. The next question is then: How do we mutate SARS-CoV-2 such that it 
becomes optimally attenuated without it dying out from being totally unable to replicate.  A strategy 
would be to compare the N sequences and disorder patterns of a CoV with a lower PIDN to those of 
SARS-CoV-2. Figure 4A represents the PONDR® VLXT plots for SARS-CoV-2 (blue), SARS-
CoV (red), and HCOV-HKU1 (dashed green). Disordered regions are denoted by the PONDR® 
VLXT scores of 0.5 or above. Keeping in mind that PIDN of SARS-CoV-2, SARS-CoV, and 
HCOV-HKU1 are 48%, 50%, and 37% respectively, we can see plenty of regions, which are 
disordered in SARS-CoV-2 but are not in HCOV-HKU1. These regions make good potential targets 
in the development of vaccine candidates. It should be reminded that HCOV-HKU1 was chosen 
because of its lowest PIDN, but there could also be other good N protein with low PID that can be 
used to compare with SARS-CoV-2 N disorder pattern.   
 
Sequence analysis  
Upon a study of Figure 4A, one region that sticks out is a disorder peak around locations 74-99, which 
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is labelled as 'X' in the graph. Apparently, this is a region, where the largest differences in disorder 
propensity lies, not just between SARS-CoV-2 and HCOV-HKU1, but also between SARS-CoV-2 and 
SARS-CoV. This area falls within the RNA binding domain approximately at locations 1-140. Figure 
4B shows a BLASTP (https://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE=Proteins) alignment of SARS-
CoV and SARS-CoV-2 of part of the N proteins.  A large gap in disorder differences can be found 
around locations 17-27 (Figure 4A-B) that is likely to be responsible for the slight difference (48% Vs, 
50%) in N PIDs between SARS-CoV-2 and SARS-CoV.  The source of the differences can be found in 
a specific mutation, within the same region. This involves a single amino-acid mutation of S (Serine)  
to T (Threonine) (Figure 4B) that can be seen when we compare SARS-CoV-2 to SARS-CoV. Serine 
(S) is more polar than threonine(T) and is therefore more disorder inducing. [17-19]. 
 We can also see, in Figure 4C, a large number of amino-acid replacements from polar residues 
to non-polar residues when we compare the sequences of SARS-CoV-2 and HCOV-HKU1 N proteins 
respectively. Disorder and order inducting residues are generally polar and non-polar respectively [17-
19]. All these provide for  a wide range of potential mutations available for use in order to induce 
greater order to SARS-CoV-2 N protein while attempting to attenuate the virus.   
The nature of M protein: Hidden risks and feasibility of vaccine 
development 
The risks of genetically manipulating M  
We have seen how a more rigid M causes greater contagiousness by allowing the virus to be more 
resistant to antimicrobial enzymes found in body fluid and also to be more resilient outside the 
body. It is therefore a possible temptation to contemplate manipulating M so that the attenuated 
virus to decrease the chances of the vaccine virus or mutated form in spreading. Before we ponder 
on this possibility, we need to have a better understanding of the risks of increasing M disorder 
based on what is known about the pathogenesis of viruses with disordered outer shell.  
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Increasing M PID may place greater risks of morbidity, such as fetal morbidity and 
reduced effectiveness of vaccine 
Figure 5 summarizes the dangers and implications of viruses with higher outer shell. While we 
have seen that greater inner shell disorder causes virulence, viruses with higher levels of outer shell 
disorder, on the other hand, can cause higher morbidity. For example, ZIKV can inflict higher 
morbidity on fetus by causing microcephaly; i.e. small head and brain. Figure 5A shows that ZIKV 
has a higher outer shell disorder (PIDM = 29%) [11], which is exceptionally high especially among 
its flavivirus cousins. This is in sharp contrast to the DENV PIDM of 10% and although DENV2 
causes microcephaly but it does it at a much lower rate [11]. As for the SARS-CoV-2 and SARS-
CoV, while more data are needed, it is currently observed that the viruses do generally harm the 
fetus of a pregnant woman [48]. The main reason for the link between outer shell disorder and 
morbidity has to do with the greater ability of viruses with higher outer shell disorder to penetrate 
organs as the placenta and brain [7,10-11,24,26,27]. This is likely the result of greater binding 
promiscuity resulting from higher disorder.   
Yet another risk of increasing levels of disorder in M protein in the attempt to attenuate a virus is 
that it could backfire and actually thwart the effectiveness of vaccine by reducing the ability of the 
vaccine to elicit immune response. It has been known that some viruses, including HIV, HSV, and 
HCV evade the host immune system by having highly disordered outer shells, and thereby 
decreasing the ability of antibodies to bind firmly to the viral surface glycoproteins [7,24,27]. 
Further discussion on this immune-evasion mechanism is presented in the next paragraph.  
 
Feasibility of SARS-CoV-2 vaccine development: Encouraging news 
A nightmare scenario that many scientists fear is the possibility the SARS-CoV-2 vaccine may 
never be developed, as highlighted by HIV, HCV and HSV, where the vaccine search has taken 
about 40, 30 and 100 years respectively with no success. The research in this paper is actually a 
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spin-off from a parent research that began about 15 years ago [7,18,20,22,23]. The latter has found 
that the reason that it is difficult to find effective vaccines for these viruses has to do with the way 
that they are transmitted, and their relationships with sexual transmission that leads to the highly 
disordered outer shells. As a result of the motions of the outer shell proteins, neutralizing antibodies 
are not able to bind tightly to the surface proteins. Figure 5B provides encouraging news as the 
outer shell PIDs of HSV, HCV, and HIV look nothing like those of SARS-CoV, SARS-CoV-2 
(Figure 5A), and all CoV samples that we have examined in Table 1.  The HIV-1, HCV, and HSV 
maximal outer shell PIDs reach 70%, 53% and 63% [27] respectively, in contrast to SARS-CoV and 
SARS-CoV-2 PIDM values of 8% and 6%.  
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Figure legends 
 
Figure 1.  PIDM values of SARS-CoV and other CoV. SARS-CoV-2 has among the hardest outer 
shell as seen by its low PIDM (^%). 
 
Figure 2. Relationships between the case-fatality rate (CFR) and the inner shell disorder. A. Link 
between SARS-CoV/SAR-CoV-2 PIDN and CFR. B. Correlation between NiV PIDN and CFR ( p< 
0.001, r2 = 0.83),  NiV is of Paramyxoviridae family. C. Correlation between Filovirus (Marburg 
Virus and EBOV) NP (nucleocapsid) PID and CFR ( p < 001, r2 = 0.6). D. Correlation between 
flavivirus DENV C (capsid) PID and CFR ( p < 001, r2 = 0.88).  The abbreviations used are: 
REBOV (Reston EBOV),  BEBOV (Bundibugyo EBOV), SEBOV (Sudan EBOV), ZEBOB (Zaire 
EBOV). TBEV (Tick-borne encephalitis virus), TBEV-Si (TBEV-Siberia), TBEV-FE (TBEV-Far 
East), TBEV-Eu (TBEV-Europe) and WNV (West Nile Virus) 
  
Figure 3.  3D crystal structure representation of the RNA binding regions of the CoV N proteins 
with disordered regions represented in red. A. SARS-CoV-2 N protein (6m3m.pdb). B. Murine 
hepatitis virus (MHV) N protein (4hdv.pdb).  
 
Figure 4. Comparative PONDR® VLXT plots of SARS-CoV, SARS-CoV-2 and HCOV-HKU1 N 
proteins with BLASTP alignments.   A. PONDR® VLXT Plots. Regions with VLXT scors of 0.5 
and above are disordered. X is a peak of interest.  B. BLASTP alignment of SARS-CoV-2 and 
HCOV-HKU1 N proteins with disorder annotation. C. BLASTP alignment of SARS-CoV-2 and 
HCOV-HKU1 N proteins with disorder annotation. The RNA-binding region lies around locations 
1-145. Much of the differences in disorder can be found in this region of interest. 
  
Figure 5. Implications and risks of viruses with greater disorder at the outer shell protein A. Links 
between fetal morbidity and inner shell disorder. Previous research has found a strong correlation 
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between fetal morbidity and M disorder among various strains of ZIKV and DENV2 ( p < 001, r2 = 
0.8). B.  Comparative PID bar chart of viruses with no vaccines, HIV, HCV and HSV. A high level 
of disorder is missing in SARS-CoV-2 M protein (see also Figure 5A) , unlike the HIV, HCV and 
HSV outer shells. 
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Table 1. Grouping of coronaviruses by mainly N disorder  to predict respiratory and fecal-oral transmission 
potentials  (Statistical Analyses:Two-Way ANOVA, p < 0.00), ( p< 0.001,  r2 = 0.8) .  
Shell 
Disorder 
Category 
Coronavirus M PID %  
(UniProt 
/Genbank 
Accession Code)a 
N PID % 
(UniProt/Genbank 
Accession Code)b 
M  
PID 
N 
PID 
Remarks 
A HCoV-229E 
IBV(Avian) 
P15422 
P69606 
P15130 
Q8JMI6 
23 
10 
56 
56 
Higher Levels 
of Respiratory 
Transmission 
Lower Levels 
of Fecal-oral 
Transmission  
B Bovine 
PEDV(Porcine) 
Canine(Resp.) 
HCoV-OC43 
SARS-CoV 
HCoV-NL63 
Bat-HKU4 
SARS-Cov-2 
Bats 
Bat-HKU5 
P69704 
P59771 
A3EXD6 
Q4VID2 
P59596 
Q6Q1R9 
A3EXA0 
QHD43419.1d 
A3EXD6 
A3EXD6 
Q8V432 
Q07499 
A3E2F7 
P33469 
P59595 
Q6Q1R8 
A3EXA1 
QHD43423.2d 
Q3LZX4 
A3EXD7b 
7.4 
8 
6.5 
7 
8 
11 
16 
6 
11.5 
11 
 
53 
51 
51 
51 
50 
49 
48 
48 
47 
47 
 
Intermediate 
Levels of 
Respiratory 
and Fecal-oral 
Transmission 
C MHV(Murine) 
MERS-CoV 
TGEV(Porcine) 
Canine(Ent.) 
HCoV-HKU1 
 
Q9JEB4 
9(K0BU37 
P09175 
B8RIR2 
Q14EA7 
Po3416 
K0BVN3 
P04134 
Q04700 
Q0ZME3 
 
8 
9 
14 
8 
4 
46 
44 
43 
40 
37 
Lower Levels 
of Respiratory 
Transmission 
Higher Levels 
of Fecal-oral 
Transmission  
aM PID refers to the percentage of intrinsic 
disorder (PID) of the membrane protein (M). PID 
is measured by the number of residues predicted to 
be disordered divided by the total number of 
disorder. M PID predicts the hardness of the 
virion. M is considered to be one of the outer 
shell.  
bN  protein refers to the nucleocapsid protein, 
which is an inner shell protein,  
cSARS-CoV-2    
dGenbank accession code, 
https://www.ncbi.nlm.nih.gov/nuccore/MN908947 
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Figure 3 
 
 
 
Preprints (www.preprints.org)  |  NOT PEER-REVIEWED  |  Posted: 7 May 2020                   
Figure 4  
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